Evidence map›Paper›PMID 25162584›Full record

ArticlePloS one2014

SDF-1 chemokine signalling modulates the apoptotic responses to iron deprivation of clathrin-depleted DT40 cells.

Alena Pance, Frank R Morrissey-Wettey, Helen Craig, Alison Downing, Richard Talbot, Antony P Jackson

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alena PanceThe Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
Frank R Morrissey-WetteyDepartment of Biochemistry, Hopkins Building, University of Cambridge, Cambridge, United Kingdom.
Helen CraigDepartment of Biochemistry, Hopkins Building, University of Cambridge, Cambridge, United Kingdom.
Alison DowningRoslin Institute, Roslin, Midlothian, Scotland, United Kingdom.
Richard TalbotRoslin Institute, Roslin, Midlothian, Scotland, United Kingdom.
Antony P JacksonDepartment of Biochemistry, Hopkins Building, University of Cambridge, Cambridge, United Kingdom.

Funding

Biotechnology and Biological Sciences Research Council BB/D001242/1
6 · The paper itself

Abstract

We have previously deleted both endogenous copies of the clathrin heavy-chain gene in the chicken pre B-cell-line DT40 and replaced them with clathrin under the control of a tetracycline-regulatable promoter (Tet-Off). The originally derived cell-line DKO-S underwent apoptosis when clathrin expression was repressed. We have also described a cell-line DKO-R derived from DKO-S cells that was less sensitive to clathrin-depletion. Here we show that the restriction of transferrin uptake, resulting in iron deprivation, is responsible for the lethal consequence of clathrin-depletion. We further show that the DKO-R cells have up-regulated an anti-apoptotic survival pathway based on the chemokine SDF-1 and its receptor CXCR4. Our work clarifies several puzzling features of clathrin-depleted DT40 cells and reveals an example of how SDF-1/CXCR4 signalling can abrogate pro-apoptotic pathways and increase cell survival. We propose that the phenomenon described here has implications for the therapeutic approach to a variety of cancers.

Indexed as

Iron DeficienciesAnimalsApoptosisCell LineCell SurvivalChemokine CXCL12ChickensClathrin Heavy ChainsCulture MediaGene Expression ProfilingGene Expression RegulationOligonucleotide Array Sequence AnalysisPrecursor Cells, B-LymphoidPromoter Regions, GeneticReceptors, CXCR4Signal TransductionChemokine CXCL12Clathrin Heavy ChainsCulture MediaReceptors, CXCR4TetracyclineTransferrin

Identifiers

PMID25162584
PMCPMC4146602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.